FDA Import Refusal SCS-2993197-1/11/1 — SPH Zhongxi Pharmaceutical Co., Ltd.
The FDA refused shipment SCS-2993197-1/11/1 from SPH Zhongxi Pharmaceutical Co., Ltd. (China) on Dec 9, 2020. The refused product falls under Drugs and Biologics — HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Dec 9, 2020
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 62LAY29 HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
- Charges
- 75